TRIO
Triple functional domain protein
Also known as: ARHGEF23, TRIO_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75962
- Gene
- TRIO
- Ensembl
- ENSG00000038382
- Chromosome
- 5
- Canonical length
- 3097 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Vesicles,Plasma membrane,Primary cilium,Primary cilium tip,Basal body,Cytosol
OverviewNCBI Gene
This gene encodes a large protein that functions as a GDP to GTP exchange factor. This protein promotes the reorganization of the actin cytoskeleton, thereby playing a role in cell migration and growth. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Canonical amino-acid sequenceUniProt
3097 residues, UniProt reviewed canonical sequence.
>O75962|TRIO
1 MSGSSGGAAA PAASSGPAAA ASAAGSGCGG GAGEGAEEAA KDLADIAAFF RSGFRKNDEM
61 KAMDVLPILK EKVAYLSGGR DKRGGPILTF PARSNHDRIR QEDLRRLISY LACIPSEEVC
121 KRGFTVIVDM RGSKWDSIKP LLKILQESFP CCIHVALIIK PDNFWQKQRT NFGSSKFEFE
181 TNMVSLEGLT KVVDPSQLTP EFDGCLEYNH EEWIEIRVAF EDYISNATHM LSRLEELQDI
241 LAKKELPQDL EGARNMIEEH SQLKKKVIKA PIEDLDLEGQ KLLQRIQSSE SFPKKNSGSG
301 NADLQNLLPK VSTMLDRLHS TRQHLHQMWH VRKLKLDQCF QLRLFEQDAE KMFDWITHNK
361 GLFLNSYTEI GTSHPHAMEL QTQHNHFAMN CMNVYVNINR IMSVANRLVE SGHYASQQIR
421 QIASQLEQEW KAFAAALDER STLLDMSSIF HQKAEKYMSN VDSWCKACGE VDLPSELQDL
481 EDAIHHHQGI YEHITLAYSE VSQDGKSLLD KLQRPLTPGS SDSLTASANY SKAVHHVLDV
541 IHEVLHHQRQ LENIWQHRKV RLHQRLQLCV FQQDVQQVLD WIENHGEAFL SKHTGVGKSL
601 HRARALQKRH EDFEEVAQNT YTNADKLLEA AEQLAQTGEC DPEEIYQAAH QLEDRIQDFV
661 RRVEQRKILL DMSVSFHTHV KELWTWLEEL QKELLDDVYA ESVEAVQDLI KRFGQQQQTT
721 LQVTVNVIKE GEDLIQQLRD SAISSNKTPH NSSINHIETV LQQLDEAQSQ MEELFQERKI
781 KLELFLQLRI FERDAIDIIS DLESWNDELS QQMNDFDTED LTIAEQRLQH HADKALTMNN
841 LTFDVIHQGQ DLLQYVNEVQ ASGVELLCDR DVDMATRVQD LLEFLHEKQQ ELDLAAEQHR
901 KHLEQCVQLR HLQAEVKQVL GWIRNGESML NAGLITASSL QEAEQLQREH EQFQHAIEKT
961 HQSALQVQQK AEAMLQANHY DMDMIRDCAE KVASHWQQLM LKMEDRLKLV NASVAFYKTS
1021 EQVCSVLESL EQEYKREEDW CGGADKLGPN SETDHVTPMI SKHLEQKEAF LKACTLARRN
1081 ADVFLKYLHR NSVNMPGMVT HIKAPEQQVK NILNELFQRE NRVLHYWTMR KRRLDQCQQY
1141 VVFERSAKQA LEWIHDNGEF YLSTHTSTGS SIQHTQELLK EHEEFQITAK QTKERVKLLI
1201 QLADGFCEKG HAHAAEIKKC VTAVDKRYRD FSLRMEKYRT SLEKALGISS DSNKSSKSLQ
1261 LDIIPASIPG SEVKLRDAAH ELNEEKRKSA RRKEFIMAEL IQTEKAYVRD LRECMDTYLW
1321 EMTSGVEEIP PGIVNKELII FGNMQEIYEF HNNIFLKELE KYEQLPEDVG HCFVTWADKF
1381 QMYVTYCKNK PDSTQLILEH AGSYFDEIQQ RHGLANSISS YLIKPVQRIT KYQLLLKELL
1441 TCCEEGKGEI KDGLEVMLSV PKRANDAMHL SMLEGFDENI ESQGELILQE SFQVWDPKTL
1501 IRKGRERHLF LFEMSLVFSK EVKDSSGRSK YLYKSKLFTS ELGVTEHVEG DPCKFALWVG
1561 RTPTSDNKIV LKASSIENKQ DWIKHIREVI QERTIHLKGA LKEPIHIPKT APATRQKGRR
1621 DGEDLDSQGD GSSQPDTISI ASRTSQNTLD SDKLSGGCEL TVVIHDFTAC NSNELTIRRG
1681 QTVEVLERPH DKPDWCLVRT TDRSPAAEGL VPCGSLCIAH SRSSMEMEGI FNHKDSLSVS
1741 SNDASPPASV ASLQPHMIGA QSSPGPKRPG NTLRKWLTSP VRRLSSGKAD GHVKKLAHKH
1801 KKSREVRKSA DAGSQKDSDD SAATPQDETV EERGRNEGLS SGTLSKSSSS GMQSCGEEEG
1861 EEGADAVPLP PPMAIQQHSL LQPDSQDDKA SSRLLVRPTS SETPSAAELV SAIEELVKSK
1921 MALEDRPSSL LVDQGDSSSP SFNPSDNSLL SSSSPIDEME ERKSSSLKRR HYVLQELVET
1981 ERDYVRDLGY VVEGYMALMK EDGVPDDMKG KDKIVFGNIH QIYDWHRDFF LGELEKCLED
2041 PEKLGSLFVK HERRLHMYIA YCQNKPKSEH IVSEYIDTFF EDLKQRLGHR LQLTDLLIKP
2101 VQRIMKYQLL LKDFLKYSKK ASLDTSELER AVEVMCIVPR RCNDMMNVGR LQGFDGKIVA
2161 QGKLLLQDTF LVTDQDAGLL PRCRERRIFL FEQIVIFSEP LDKKKGFSMP GFLFKNSIKV
2221 SCLCLEENVE NDPCKFALTS RTGDVVETFI LHSSSPSVRQ TWIHEINQIL ENQRNFLNAL
2281 TSPIEYQRNH SGGGGGGGSG GSGGGGGSGG GGAPSGGSGH SGGPSSCGGA PSTSRSRPSR
2341 IPQPVRHHPP VLVSSAASSQ AEADKMSGTS TPGPSLPPPG AAPEAGPSAP SRRPPGADAE
2401 GSEREAEPIP KMKVLESPRK GAANASGSSP DAPAKDARAS LGTLPLGKPR AGAASPLNSP
2461 LSSAVPSLGK EPFPPSSPLQ KGGSFWSSIP ASPASRPGSF TFPGDSDSLQ RQTPRHAAPG
2521 KDTDRMSTCS SASEQSVQST QSNGSESSSS SNISTMLVTH DYTAVKEDEI NVYQGEVVQI
2581 LASNQQNMFL VFRAATDQCP AAEGWIPGFV LGHTSAVIVE NPDGTLKKST SWHTALRLRK
2641 KSEKKDKDGK REGKLENGYR KSREGLSNKV SVKLLNPNYI YDVPPEFVIP LSEVTCETGE
2701 TVVLRCRVCG RPKASITWKG PEHNTLNNDG HYSISYSDLG EATLKIVGVT TEDDGIYTCI
2761 AVNDMGSASS SASLRVLGPG MDGIMVTWKD NFDSFYSEVA ELGRGRFSVV KKCDQKGTKR
2821 AVATKFVNKK LMKRDQVTHE LGILQSLQHP LLVGLLDTFE TPTSYILVLE MADQGRLLDC
2881 VVRWGSLTEG KIRAHLGEVL EAVRYLHNCR IAHLDLKPEN ILVDESLAKP TIKLADFGDA
2941 VQLNTTYYIH QLLGNPEFAA PEIILGNPVS LTSDTWSVGV LTYVLLSGVS PFLDDSVEET
3001 CLNICRLDFS FPDDYFKGVS QKAKEFVCFL LQEDPAKRPS AALALQEQWL QAGNGRSTGV
3061 LDTSRLTSFI ERRKHQNDVR PIRSIKNFLQ SRLLPRVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRIO can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- ovary: 18 nTPM
- endometrium: 14 nTPM
- blood vessel: 11 nTPM
- adipose tissue: 11 nTPM
- breast: 10 nTPM
- colon: 10 nTPM
Single-cell type
- epididymal basal cells: 1,113 nCPM
- somatotrophs: 1,042 nCPM
- oligodendrocyte progenitor cells: 824 nCPM
- mast cells: 788 nCPM
- choroid plexus epithelial cells: 763 nCPM
- lactotrophs: 722 nCPM
Immune cell
- naive B-cell: 1.4 nTPM
- NK-cell: 1.4 nTPM
- intermediate monocyte: 0.6 nTPM
- memory B-cell: 0.6 nTPM
- myeloid DC: 0.5 nTPM
- non-classical monocyte: 0.4 nTPM
Brain region
- choroid plexus: 52 nTPM
- cerebral cortex: 48 nTPM
- cerebellum: 46 nTPM
- hippocampal formation: 43 nTPM
- thalamus: 42 nTPM
- hypothalamus: 40 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRIO.
Disease | AllUniProt
Conditions TRIO is implicated in, by any mechanism.
- Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) MIM:617061
- Intellectual developmental disorder, autosomal dominant 63, with macrocephaly (MRD63) MIM:618825
Disease | GeneticClinVar
183 pathogenic / likely-pathogenic of 1,943 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome
- Intellectual developmental disorder, autosomal dominant 63, with macrocephaly
- Inborn genetic diseases
- TRIO-related disorder
- Intellectual disability
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.14
- gnomAD pLI
- 1
- gnomAD missense Z
- 5.32
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon guidance
- cell surface receptor protein tyrosine phosphatase signaling pathway
- negative regulation of fat cell differentiation
- neuron projection morphogenesis
- postsynaptic modulation of chemical synaptic transmission
- regulation of small GTPase mediated signal transduction
Molecular functions
- ATP binding
- guanyl-nucleotide exchange factor activity
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dbl homology domain
- Protein kinase domain
- CRAL-TRIO lipid binding domain
- SH3 domain
- Pleckstrin homology domain
- Spectrin repeat
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- PH-like domain superfamily
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Spectrin/alpha-actinin
- Kalirin/Triple functional domain protein, SH3 domain 1
- Dbl homology (DH) domain superfamily
- SH3-like domain superfamily
- Immunoglobulin-like domain superfamily
- CRAL-TRIO lipid binding domain superfamily
- Kalirin/Triple functional domain protein, SH3 domain 2
- Kalirin/Triple functional domain protein, pleckstrin homology (PH) domain 1
- Rho GTPase-activating Guanine Nucleotide Exchange Factors
- SOS1/NGEF-like, PH domain
- Kalirin/TRIO-like, spectrin repeats
- SH3 domain
- Protein kinase domain
- Spectrin repeat
- RhoGEF domain
- Immunoglobulin I-set domain
- Divergent CRAL/TRIO domain
- SH3-RhoGEF linking unstructured region
- SOS1/NGEF-like PH domain
- Kalirin-like, spectrin repeats
- Kalirin, SH3
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRIO in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRIO as an antibody target. Whether an autoantibody or antibody against TRIO could matter depends on whether native TRIO is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRIO is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRIO as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...